Status:
COMPLETED
GORE® TAG® Thoracic Endoprosthesis French Mandatory Registry
Lead Sponsor:
W.L.Gore & Associates
Conditions:
Aortic Aneurysm, Thoracic
Descending Thoracic Aortic Dissection
Eligibility:
All Genders
18+ years
Brief Summary
This is a French Registry mandated by the French National Health Authority assessing long-term (5-years) safety of the GORE® TAG® Thoracic Endoprosthesis treating diseases of the thoracic aorta.
Detailed Description
Endovascular therapy to treat thoracic disease seems to provide a plausible benefit compared to surgery in terms of operative mortality and severe morbidity. The French National Health Authority (HAS)...
Eligibility Criteria
Inclusion
- Patient where a GORE® TAG® or Conformable GORE® TAG® Thoracic Endoprosthesis is implanted (successfully or not) for the treatment of disease of the descending thoracic aorta.
- Patient who had previously consented to the collection and processing of personal medical data.
- Patient older than 18 years at the time of treatment.
Exclusion
- Patients who have already received treatment with a thoracic endoprosthesis other than the GORE® TAG® or Conformable GORE® TAG® Thoracic Endoprosthesis and for whom 'revision' or reintervention is required.
- Patients whose clinical follow-up is not possible (i.e. patients who cannot return for control visits because they live abroad).
Key Trial Info
Start Date :
October 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2022
Estimated Enrollment :
154 Patients enrolled
Trial Details
Trial ID
NCT02266342
Start Date
October 1 2014
End Date
April 1 2022
Last Update
April 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopitaux Universitaire de Strasbourg
Strasbourg, France, 67091